Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.15 trillion and total revenue of $110.17 billion.
Market Cap
1.15T
Revenue
110.17B
Profits
-39.72B
PE Ratio
n/a
Profit Margin
-36.05%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.93B | 0.87% | 1,004,561 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.60B | -0.32% | 746,951 | 14.34B |
| 3 | ARGX | argenx SE | 49.28B | 1.20% | 337,012 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.16B | 3.38% | 967,690 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.90B | -1.30% | 304,168 | 5.34B |
| 6 | INSM | Insmed Incorporated | 32.62B | -2.37% | 2,079,484 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.94B | 1.11% | 2,859,449 | 2.38B |
| 8 | RVMD | Revolution Medicines, Inc. | 27.01B | 41.35% | 14,720,527 | - |
| 9 | BNTX | BioNTech SE | 24.45B | 1.26% | 1,361,854 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.72B | 2.62% | 3,359,265 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 20.10B | -0.55% | 6,651,817 | 1.94B |
| 12 | INCY | Incyte Corporation | 19.02B | -0.54% | 1,186,408 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.27B | -0.18% | 2,039,456 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 15.53B | 1.83% | 2,029,088 | - |
| 15 | ASND | Ascendis Pharma A/S | 15.36B | 3.87% | 1,063,596 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.10B | 4.40% | 2,589,420 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.38B | -0.29% | 1,650,859 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.06B | 1.17% | 363,762 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 12.02B | 0.57% | 976,050 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.68B | 1.56% | 2,224,727 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.55B | 0.64% | 1,442,167 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.71B | -3.83% | 1,511,139 | 5.37M |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.12B | 0.12% | 549,550 | 638.50M |
| 24 | TECH | Bio-Techne Corporation | 9.00B | 3.58% | 1,847,216 | 1.22B |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.93B | -2.07% | 1,765,130 | 1.09B |
| 26 | PCVX | Vaxcyte, Inc. | 8.89B | 1.43% | 950,099 | - |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.83B | 0.27% | 269,405 | 7.46M |
| 28 | CYTK | Cytokinetics, Incorporated | 8.22B | 2.63% | 1,728,551 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 8.15B | 0.92% | 321,750 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.94B | -1.24% | 1,042,690 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.87B | 3.25% | 240,861 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.54B | 0.27% | 9,619,742 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.23B | 4.09% | 460,706 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 6.81B | 0.24% | 179,112 | - |
| 35 | ACLX | Arcellx, Inc. | 6.74B | 0.03% | 486,092 | 22.29M |
| 36 | APGE | Apogee Therapeutics, Inc. | 6.41B | 0.54% | 355,798 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.23B | -1.26% | 1,088,545 | 46.02M |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.12B | 0.23% | 2,373,707 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.04% | 6,738,825 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.93B | 2.87% | 506,820 | 189.76M |
| 41 | COGT | Cogent Biosciences, Inc. | 5.88B | 0.41% | 2,143,859 | - |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.83B | 2.52% | 665,686 | 1.73B |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | 1.36% | 571,253 | 521.31M |
| 44 | CELC | Celcuity Inc. | 5.82B | 2.78% | 567,849 | - |
| 45 | CGON | CG Oncology, Inc. | 5.72B | - | 879,645 | 4.04M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.69B | -0.88% | 1,960,277 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.59B | 0.34% | 498,400 | 7.50M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.41B | 5.98% | 1,961,495 | 812.03M |
| 49 | CRSP | CRISPR Therapeutics AG | 5.26B | 7.05% | 1,843,751 | 3.51M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | 0.12% | 5,828,204 | 1.00B |
| 51 | IMVT | Immunovant, Inc. | 5.11B | 2.53% | 804,138 | - |
| 52 | ERAS | Erasca, Inc. | 5.07B | -4.12% | 14,071,408 | - |
| 53 | TGTX | TG Therapeutics, Inc. | 4.99B | 0.18% | 1,234,507 | 616.29M |
| 54 | SYRE | Spyre Therapeutics, Inc. | 4.97B | 23.36% | 5,360,876 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | 0.26% | 639,358 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.61B | 3.32% | 1,261,559 | 761.41M |
| 57 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 1,938,602 | 634.21M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.26B | 4.16% | 168,533 | 268.09M |
| 59 | NAMS | NewAmsterdam Pharma Company N.V. | 4.17B | 4.29% | 724,155 | 22.50M |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.06B | 2.19% | 1,962,031 | - |
| 61 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.05B | -1.98% | 868,911 | 7.70M |
| 62 | GPCR | Structure Therapeutics Inc. | 3.84B | -0.48% | 467,887 | - |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.77B | 6.64% | 374,957 | 803.79M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.66B | -1.29% | 2,038,007 | 1.07B |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.63B | 3.11% | 689,136 | - |
| 66 | LEGN | Legend Biotech Corporation | 3.27B | -2.59% | 1,763,029 | 1.03B |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.14B | 1.71% | 1,522,108 | - |
| 68 | VERA | Vera Therapeutics, Inc. | 3.12B | -2.95% | 1,191,525 | - |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.09B | 1.60% | 1,107,334 | 588.99M |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | 0.12% | 294,931 | 451.36M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.08B | 0.99% | 1,107,623 | - |
| 72 | TNGX | Tango Therapeutics, Inc. | 3.08B | 8.07% | 4,071,289 | 62.38M |
| 73 | ORKA | Oruka Therapeutics, Inc. | 3.04B | 3.02% | 1,518,128 | - |
| 74 | BEAM | Beam Therapeutics Inc. | 3.00B | 10.03% | 3,345,557 | 139.74M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | -0.37% | 812,871 | 376.07M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.88B | 7.61% | 10,039,099 | 218.71M |
| 77 | ALMS | Alumis Inc. | 2.86B | -2.30% | 1,238,669 | 24.05M |
| 78 | TVTX | Travere Therapeutics, Inc. | 2.84B | 6.01% | 2,501,793 | 490.73M |
| 79 | RCUS | Arcus Biosciences, Inc. | 2.81B | 0.22% | 755,142 | 247.00M |
| 80 | RLAY | Relay Therapeutics, Inc. | 2.73B | 2.14% | 2,812,238 | 15.36M |
| 81 | SLNO | Soleno Therapeutics, Inc. | 2.72B | 0.02% | 3,054,341 | 190.41M |
| 82 | MANE | Veradermics, Incorporated | 2.66B | 3.72% | 671,474 | - |
| 83 | ELVN | Enliven Therapeutics, Inc. | 2.62B | -3.29% | 1,134,225 | - |
| 84 | IRON | Disc Medicine, Inc. | 2.61B | 3.23% | 395,269 | - |
| 85 | KOD | Kodiak Sciences Inc. | 2.59B | -2.69% | 1,015,388 | - |
| 86 | IMNM | Immunome, Inc. | 2.56B | 4.38% | 1,070,545 | 6.94M |
| 87 | CLDX | Celldex Therapeutics, Inc. | 2.56B | 1.09% | 691,118 | 1.55M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.47B | 7.01% | 5,438,695 | 510.17M |
| 89 | ZLAB | Zai Lab Limited | 2.40B | 3.19% | 449,266 | 460.16M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.32B | 1.42% | 1,472,452 | 673.00M |
| 91 | NKTR | Nektar Therapeutics | 2.31B | 3.81% | 880,122 | 55.23M |
| 92 | AAPG | Ascentage Pharma Group International | 2.31B | 0.47% | 1,880 | 82.08M |
| 93 | SRPT | Sarepta Therapeutics, Inc. | 2.29B | 2.88% | 1,926,557 | 2.20B |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.24B | 2.03% | 652,826 | - |
| 95 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.09% | 920,724 | 158.18M |
| 96 | DFTX | Definium Therapeutics, Inc. | 2.22B | 3.34% | 2,022,645 | - |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | 10.48% | 3,126,094 | 276.98M |
| 98 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | -0.78% | 884,635 | 172.35M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 1.90% | 913,956 | 283.06M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.07B | 2.10% | 772,262 | 184.42M |
| 101 | CAPR | Capricor Therapeutics, Inc. | 1.99B | 10.71% | 2,308,165 | 11.13M |
| 102 | ANAB | AnaptysBio, Inc. | 1.98B | -1.95% | 602,151 | 234.60M |
| 103 | AGIO | Agios Pharmaceuticals, Inc. | 1.94B | 0.70% | 693,824 | 54.03M |
| 104 | ZYME | Zymeworks Inc. | 1.93B | -0.57% | 512,726 | 105.97M |
| 105 | OCUL | Ocular Therapeutix, Inc. | 1.93B | 0.80% | 2,846,153 | 51.95M |
| 106 | TYRA | Tyra Biosciences, Inc. | 1.92B | 1.02% | 1,223,929 | - |
| 107 | SION | Sionna Therapeutics, Inc. | 1.88B | 10.24% | 382,801 | - |
| 108 | GLPG | Galapagos NV | 1.85B | 0.56% | 131,801 | 1.31B |
| 109 | PVLA | Palvella Therapeutics, Inc. | 1.85B | 1.48% | 178,128 | - |
| 110 | MESO | Mesoblast Limited | 1.84B | -2.00% | 300,442 | 65.38M |
| 111 | PHVS | Pharvaris N.V. | 1.82B | 4.69% | 417,307 | - |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | 4.27% | 8,786,873 | 74.68M |
| 113 | INVA | Innoviva, Inc. | 1.78B | 0.88% | 548,525 | 411.33M |
| 114 | VCEL | Vericel Corporation | 1.75B | 2.20% | 751,426 | 276.26M |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.71B | 1.06% | 869,613 | - |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.68B | 5.71% | 3,298,280 | 67.67M |
| 117 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | 0.55% | 376,065 | 868.45M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.66B | 1.40% | 145,004 | - |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.65B | -0.75% | 981,003 | 71.78M |
| 120 | GENB | Generate Biomedicines, Inc. | 1.63B | 12.18% | 377,731 | 31.89M |
| 121 | NUVB | Nuvation Bio Inc. | 1.61B | 2.17% | 1,957,785 | 62.90M |
| 122 | OCS | Oculis Holding AG | 1.60B | -0.66% | 215,429 | 1.51M |
| 123 | IMCR | Immunocore Holdings plc | 1.60B | 1.35% | 582,169 | 400.02M |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.59B | 1.84% | 238,474 | - |
| 125 | MBX | MBX Biosciences, Inc. | 1.56B | 5.84% | 300,117 | - |
| 126 | ARDX | Ardelyx, Inc. | 1.55B | 2.43% | 2,963,942 | 407.32M |
| 127 | BHVN | Biohaven Ltd. | 1.52B | 10.36% | 2,288,583 | - |
| 128 | VRDN | Viridian Therapeutics, Inc. | 1.51B | -1.00% | 1,860,367 | 70.85M |
| 129 | SVRA | Savara Inc. | 1.50B | 4.59% | 1,184,086 | - |
| 130 | NBTX | Nanobiotix S.A. | 1.50B | 5.97% | 53,610 | 38.27M |
| 131 | VIR | Vir Biotechnology, Inc. | 1.49B | -2.00% | 1,651,190 | 68.56M |
| 132 | PGEN | Precigen, Inc. | 1.48B | 0.24% | 1,703,224 | 9.68M |
| 133 | IMTX | Immatics N.V. | 1.46B | 4.22% | 311,821 | 56.67M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.45B | 4.83% | 429,698 | - |
| 135 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | -6.49% | 17,946,413 | 263.50M |
| 136 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | 0.40% | 799,008 | 123.67M |
| 137 | OLMA | Olema Pharmaceuticals, Inc. | 1.39B | -1.06% | 795,596 | - |
| 138 | ATAI | AtaiBeckley Inc. | 1.38B | 4.12% | 2,340,940 | 4.09M |
| 139 | WVE | Wave Life Sciences Ltd. | 1.37B | 1.11% | 2,644,804 | 42.73M |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.36B | 2.74% | 1,274,488 | 2.50M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.32B | 2.62% | 728,861 | - |
| 142 | NVAX | Novavax, Inc. | 1.32B | -0.12% | 2,774,053 | 1.12B |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 0.46% | 559,030 | - |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 1.27B | -1.56% | 1,583,973 | 9.77M |
| 145 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 2.94% | 434,211 | 10.00M |
| 146 | DBVT | DBV Technologies S.A. | 1.25B | 7.53% | 394,437 | 5.64M |
| 147 | EYPT | EyePoint, Inc. | 1.21B | 2.33% | 956,165 | 31.37M |
| 148 | PHAR | Pharming Group N.V. | 1.20B | -0.76% | 37,934 | 376.13M |
| 149 | AVBP | ArriVent BioPharma, Inc. | 1.18B | 5.22% | 422,829 | - |
| 150 | MPLT | MapLight Therapeutics, Inc. | 1.16B | -1.57% | 328,442 | - |
| 151 | INBX | Inhibrx Biosciences, Inc. | 1.13B | 2.91% | 213,653 | 1.30M |
| 152 | QURE | uniQure N.V. | 1.12B | 16.51% | 2,097,281 | 16.10M |
| 153 | ABCL | AbCellera Biologics Inc. | 1.11B | 3.39% | 2,916,241 | 75.13M |
| 154 | GERN | Geron Corporation | 1.11B | 3.59% | 23,450,019 | 183.88M |
| 155 | SEPN | Septerna, Inc. | 1.05B | 1.08% | 218,205 | 45.95M |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.04B | 2.46% | 1,522,536 | - |
| 157 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | 2.05% | 1,194,689 | 291.85M |
| 158 | GHRS | GH Research PLC | 1.01B | 3.94% | 214,839 | - |
| 159 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.32% | 973,507 | 175.11M |
| 160 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | 1.03% | 426,342 | 73.62M |
| 161 | URGN | UroGen Pharma Ltd. | 987.28M | -5.98% | 689,411 | 109.79M |
| 162 | IVA | Inventiva S.A. | 986.13M | -4.75% | 398,420 | 9.31M |
| 163 | EVMN | Evommune, Inc. | 972.86M | 5.88% | 257,638 | 13.00M |
| 164 | AKTS | Aktis Oncology, Inc. | 958.49M | 2.73% | 205,369 | 6.50M |
| 165 | CTMX | CytomX Therapeutics, Inc. | 949.02M | - | 6,291,402 | 76.20M |
| 166 | CMPX | Compass Therapeutics, Inc. | 936.46M | 0.58% | 2,348,974 | 850.00K |
| 167 | ANNX | Annexon, Inc. | 932.36M | -0.68% | 1,509,788 | - |
| 168 | JBIO | Jade Biosciences, Inc. | 911.86M | 3.35% | 784,887 | - |
| 169 | JANX | Janux Therapeutics, Inc. | 906.39M | -0.20% | 705,046 | 10.00M |
| 170 | XNCR | Xencor, Inc. | 885.20M | -2.82% | 771,655 | 125.58M |
| 171 | FTRE | Fortrea Holdings Inc. | 877.03M | 2.18% | 676,904 | 2.72B |
| 172 | VOR | Vor Biopharma Inc. | 865.34M | 3.23% | 1,555,677 | - |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 862.50M | -1.99% | 1,113,317 | - |
| 174 | SANA | Sana Biotechnology, Inc. | 856.64M | 3.88% | 4,689,355 | - |
| 175 | SLS | SELLAS Life Sciences Group, Inc. | 854.81M | - | 4,053,803 | - |
| 176 | ABUS | Arbutus Biopharma Corporation | 854.24M | 5.30% | 1,391,807 | 14.08M |
| 177 | TBPH | Theravance Biopharma, Inc. | 849.63M | 0.92% | 279,956 | 107.46M |
| 178 | SLDB | Solid Biosciences Inc. | 825.50M | 4.61% | 2,144,016 | - |
| 179 | DRUG | Bright Minds Biosciences Inc. | 823.16M | 1.95% | 138,097 | - |
| 180 | ANRO | Alto Neuroscience, Inc. | 822.60M | 13.04% | 787,388 | - |
| 181 | OMER | Omeros Corporation | 819.32M | -0.96% | 797,850 | - |
| 182 | MNKD | MannKind Corporation | 815.22M | 2.72% | 2,558,087 | 348.97M |
| 183 | SGP | SpyGlass Pharma, Inc. | 797.89M | 15.04% | 124,392 | - |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 794.38M | -0.62% | 854,352 | 84.28M |
| 185 | MRVI | Maravai LifeSciences Holdings, Inc. | 786.63M | -0.33% | 1,923,187 | 185.74M |
| 186 | MGTX | MeiraGTx Holdings plc | 784.33M | 7.36% | 437,011 | 81.39M |
| 187 | RLMD | Relmada Therapeutics, Inc. | 774.08M | 1.23% | 1,318,752 | - |
| 188 | KURA | Kura Oncology, Inc. | 770.24M | 0.58% | 800,787 | 67.48M |
| 189 | DSGN | Design Therapeutics, Inc. | 761.65M | 1.56% | 132,013 | - |
| 190 | FBRX | Forte Biosciences, Inc. | 749.03M | -12.80% | 523,529 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 745.96M | 12.50% | 87,821,040 | 22.00K |
| 192 | TENX | Tenax Therapeutics, Inc. | 729.36M | 0.49% | 220,203 | - |
| 193 | LXRX | Lexicon Pharmaceuticals, Inc. | 724.49M | -0.58% | 838,325 | 49.80M |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 716.29M | 6.55% | 931,423 | - |
| 195 | GYRE | Gyre Therapeutics, Inc. | 702.20M | 4.06% | 49,899 | 116.59M |
| 196 | ARVN | Arvinas, Inc. | 676.71M | -2.22% | 656,913 | 262.60M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 672.39M | 4.80% | 364,737 | - |
| 198 | PRME | Prime Medicine, Inc. | 648.11M | 6.71% | 1,809,876 | 4.63M |
| 199 | LBRX | LB Pharmaceuticals Inc | 643.36M | 4.48% | 304,211 | - |
| 200 | OCGN | Ocugen, Inc. | 604.84M | 1.70% | 5,693,846 | 4.41M |
| 201 | CBIO | Crescent Biopharma, Inc. | 597.52M | -0.99% | 208,106 | 10.84M |
| 202 | PROK | ProKidney Corp. | 588.74M | - | 2,787,012 | 893.00K |
| 203 | MDXG | MiMedx Group, Inc. | 582.38M | 1.29% | 943,432 | 418.63M |
| 204 | CRMD | CorMedix Inc. | 578.65M | 1.10% | 906,514 | 311.71M |
| 205 | LYEL | Lyell Immunopharma, Inc. | 578.54M | 10.76% | 169,006 | 36.00K |
| 206 | KYTX | Kyverna Therapeutics, Inc. | 573.72M | 6.03% | 606,282 | - |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 570.68M | 2.64% | 715,702 | 106.47M |
| 208 | TECX | Tectonic Therapeutic, Inc. | 562.55M | -2.47% | 218,635 | - |
| 209 | UPB | Upstream Bio, Inc. | 556.72M | -2.48% | 412,646 | 2.85M |
| 210 | PRTA | Prothena Corporation plc | 555.02M | -1.81% | 334,052 | 9.68M |
| 211 | RIGL | Rigel Pharmaceuticals, Inc. | 553.64M | 2.64% | 284,585 | 294.28M |
| 212 | ACRS | Aclaris Therapeutics, Inc. | 542.08M | -3.47% | 1,148,595 | 7.83M |
| 213 | ZURA | Zura Bio Limited | 538.92M | 0.53% | 567,912 | - |
| 214 | VALN | Valneva SE | 536.53M | -0.81% | 22,305 | 205.07M |
| 215 | EIKN | Eikon Therapeutics, Inc. | 534.35M | 9.67% | 409,360 | - |
| 216 | FULC | Fulcrum Therapeutics, Inc. | 514.82M | 2.38% | 570,384 | 80.00M |
| 217 | IMMX | Immix Biopharma, Inc. | 513.69M | 4.64% | 605,069 | - |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 512.56M | 2.34% | 553,931 | 85.21M |
| 219 | STTK | Shattuck Labs, Inc. | 511.69M | -2.17% | 314,567 | 1.00M |
| 220 | AGMB | AgomAb Therapeutics NV | 507.84M | -1.14% | 137,915 | - |
| 221 | LRMR | Larimar Therapeutics, Inc. | 504.87M | 0.21% | 1,438,904 | - |
| 222 | TRDA | Entrada Therapeutics, Inc. | 500.04M | 2.89% | 90,399 | 25.42M |
| 223 | ENGN | enGene Therapeutics Inc. | 497.73M | 3.19% | 210,061 | - |
| 224 | VSTM | Verastem, Inc. | 497.15M | 6.59% | 2,347,370 | 30.91M |
| 225 | IVVD | Invivyd, Inc. | 486.42M | -2.27% | 4,103,201 | 53.43M |
| 226 | ADCT | ADC Therapeutics SA | 484.04M | 1.87% | 537,979 | 81.36M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 476.41M | -0.85% | 96,690 | - |
| 228 | LXEO | Lexeo Therapeutics, Inc. | 472.68M | 6.69% | 905,324 | - |
| 229 | ABSI | Absci Corporation | 466.71M | 2.35% | 2,600,242 | 2.80M |
| 230 | RGNX | REGENXBIO Inc. | 466.62M | 2.73% | 805,969 | 170.44M |
| 231 | ASMB | Assembly Biosciences, Inc. | 463.83M | 2.89% | 143,103 | 72.30M |
| 232 | XOMA | XOMA Royalty Corporation | 460.54M | 5.20% | 229,871 | 52.15M |
| 233 | VTVT | vTv Therapeutics Inc. | 460.39M | 1.48% | 85,762 | 17.00K |
| 234 | AVIR | Atea Pharmaceuticals, Inc. | 454.93M | 0.71% | 215,344 | - |
| 235 | ANL | Adlai Nortye Ltd. | 445.02M | 8.06% | 817,852 | 5.40M |
| 236 | AURA | Aura Biosciences, Inc. | 443.28M | 1.62% | 337,076 | - |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.90M | 4.66% | 464,808 | - |
| 238 | STRO | Sutro Biopharma, Inc. | 433.90M | 1.28% | 391,280 | 102.48M |
| 239 | ARMP | Armata Pharmaceuticals, Inc. | 428.24M | 5.13% | 27,011 | 4.90M |
| 240 | PRTC | PureTech Health plc | 426.35M | 7.91% | 8,380 | 6.39M |
| 241 | VNDA | Vanda Pharmaceuticals Inc. | 423.21M | -0.83% | 1,016,707 | 216.11M |
| 242 | ALT | Altimmune, Inc. | 420.24M | -0.31% | 2,122,551 | 41.00K |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 414.11M | 1.13% | 71,982 | 66.98M |
| 244 | CLYM | Climb Bio, Inc. | 412.24M | 2.62% | 437,114 | - |
| 245 | BNTC | Benitec Biopharma Inc. | 411.06M | 5.08% | 103,847 | - |
| 246 | IPSC | Century Therapeutics, Inc. | 407.97M | 0.89% | 638,499 | 109.16M |
| 247 | YDES | YD Bio Limited | 403.64M | -8.31% | 43,320 | 510.36K |
| 248 | RCKT | Rocket Pharmaceuticals, Inc. | 397.21M | 4.30% | 3,397,797 | - |
| 249 | IRD | Opus Genetics, Inc. | 396.30M | 3.92% | 499,355 | 14.20M |
| 250 | ZNTL | Zentalis Pharmaceuticals, Inc. | 394.38M | -15.89% | 6,626,463 | 26.87M |
| 251 | AUTL | Autolus Therapeutics plc | 391.23M | -1.34% | 753,293 | 75.39M |
| 252 | DNA | Ginkgo Bioworks Holdings, Inc. | 388.82M | 3.57% | 1,019,501 | 170.16M |
| 253 | PBYI | Puma Biotechnology, Inc. | 385.14M | -2.70% | 269,567 | 228.37M |
| 254 | GLSI | Greenwich LifeSciences, Inc. | 380.86M | 6.63% | 106,757 | - |
| 255 | LCTX | Lineage Cell Therapeutics, Inc. | 376.12M | 2.03% | 927,762 | 14.56M |
| 256 | NAUT | Nautilus Biotechnology, Inc. | 375.90M | 0.68% | 306,800 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 375.50M | 0.73% | 228,907 | 35.11M |
| 258 | MNPR | Monopar Therapeutics Inc. | 375.30M | 0.16% | 169,377 | - |
| 259 | NMRA | Neumora Therapeutics, Inc. | 375.00M | 0.98% | 924,741 | - |
| 260 | RZLT | Rezolute, Inc. | 374.98M | -0.82% | 2,172,315 | - |
| 261 | NAGE | Niagen Bioscience, Inc. | 369.94M | 2.44% | 415,189 | 129.42M |
| 262 | IMRX | Immuneering Corporation | 368.52M | 3.26% | 779,055 | - |
| 263 | OVID | Ovid Therapeutics Inc. | 367.93M | 1.45% | 3,289,138 | 7.25M |
| 264 | PRLD | Prelude Therapeutics Incorporated | 360.68M | 7.11% | 177,929 | 12.14M |
| 265 | CADL | Candel Therapeutics, Inc. | 356.71M | 0.83% | 617,208 | - |
| 266 | CABA | Cabaletta Bio, Inc. | 356.23M | 2.24% | 1,493,096 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 347.14M | 0.81% | 340,283 | 72.59M |
| 268 | SRZN | Surrozen, Inc. | 342.99M | 5.89% | 262,160 | 3.48M |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 339.46M | 5.18% | 143,327 | - |
| 270 | PALI | Palisade Bio, Inc. | 333.17M | 9.34% | 3,177,662 | - |
| 271 | NGEN | NervGen Pharma Corp. | 331.01M | 0.99% | 126,060 | - |
| 272 | ACIU | AC Immune SA | 327.36M | 0.61% | 122,320 | 4.51M |
| 273 | CLLS | Cellectis S.A. | 314.39M | 19.22% | 320,659 | 79.59M |
| 274 | EDIT | Editas Medicine, Inc. | 313.19M | 8.84% | 2,392,758 | 40.52M |
| 275 | AVTX | Avalo Therapeutics, Inc. | 304.00M | -2.34% | 597,846 | 59.00K |
| 276 | LENZ | LENZ Therapeutics, Inc. | 301.94M | 6.17% | 578,072 | 19.09M |
| 277 | NGNE | Neurogene Inc. | 300.27M | -5.40% | 195,571 | 925.00K |
| 278 | PLYX | Polaryx Therapeutics, Inc. | 292.11M | 8.63% | 78,165 | - |
| 279 | IKT | Inhibikase Therapeutics, Inc. | 291.42M | 0.59% | 816,734 | 1.00 |
| 280 | ABEO | Abeona Therapeutics Inc. | 288.67M | 3.05% | 790,199 | 5.82M |
| 281 | AVXL | Anavex Life Sciences Corp. | 288.21M | 5.42% | 907,706 | - |
| 282 | SLN | Silence Therapeutics plc | 283.64M | 4.80% | 788,856 | 559.00K |
| 283 | NBP | NovaBridge Biosciences | 277.56M | 1.69% | 254,586 | - |
| 284 | FHTX | Foghorn Therapeutics Inc. | 275.30M | 2.18% | 141,071 | 30.91M |
| 285 | TARA | Protara Therapeutics, Inc. | 274.21M | 2.22% | 463,284 | - |
| 286 | SABS | SAB Biotherapeutics, Inc. | 274.08M | 4.00% | 268,276 | 114.70K |
| 287 | HELP | Cybin Inc. | 271.69M | 4.02% | 688,800 | - |
| 288 | CCCC | C4 Therapeutics, Inc. | 269.32M | 8.88% | 5,236,290 | 35.95M |
| 289 | CGEN | Compugen Ltd. | 260.97M | 6.98% | 677,750 | 72.76M |
| 290 | ALEC | Alector, Inc. | 257.14M | -4.90% | 362,210 | 21.05M |
| 291 | CHRS | Coherus Oncology, Inc. | 256.31M | 1.79% | 939,464 | 42.17M |
| 292 | ADAG | Adagene Inc. | 253.72M | 1.05% | 452,919 | 7.67M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 251.64M | 4.12% | 108,857 | 33.48M |
| 294 | NERV | Minerva Neurosciences, Inc. | 246.66M | 3.45% | 120,175 | - |
| 295 | MIST | Milestone Pharmaceuticals Inc. | 245.30M | -0.99% | 1,965,985 | 1.55M |
| 296 | ELDN | Eledon Pharmaceuticals, Inc. | 244.61M | 3.87% | 1,602,448 | - |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 243.25M | -0.60% | 113,182 | 19.39M |
| 298 | CAMP | Camp4 Therapeutics Corporation | 240.91M | 3.34% | 33,930 | 3.50M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 240.46M | 1.20% | 255,127 | 82.03M |
| 300 | ALXO | ALX Oncology Holdings Inc. | 230.31M | 2.94% | 1,353,267 | - |
| 301 | VYGR | Voyager Therapeutics, Inc. | 228.86M | 2.67% | 534,624 | 40.37M |
| 302 | MDWD | MediWound Ltd. | 226.84M | -1.12% | 94,344 | 16.96M |
| 303 | CNTX | Context Therapeutics Inc. | 226.02M | -1.20% | 1,096,895 | - |
| 304 | NVCT | Nuvectis Pharma, Inc. | 224.12M | 2.92% | 34,306 | - |
| 305 | MGNX | MacroGenics, Inc. | 220.55M | -3.61% | 925,370 | 149.50M |
| 306 | KROS | Keros Therapeutics, Inc. | 219.85M | -0.54% | 470,612 | 244.06M |
| 307 | MENS | Jyong Biotech Ltd. | 214.55M | 12.05% | 61,241 | - |
| 308 | OABI | OmniAb, Inc. | 211.38M | -0.68% | 516,669 | 18.67M |
| 309 | CDXS | Codexis, Inc. | 209.00M | 2.68% | 926,073 | 70.39M |
| 310 | FENC | Fennec Pharmaceuticals Inc. | 204.44M | 2.07% | 162,542 | 44.64M |
| 311 | ELTX | Elicio Therapeutics, Inc. | 199.41M | 6.80% | 113,081 | - |
| 312 | ENLV | Enlivex Ltd. | 198.97M | -12.82% | 1,831,957 | - |
| 313 | KRRO | Korro Bio, Inc. | 197.44M | 7.97% | 117,550 | 6.39M |
| 314 | ACHV | Achieve Life Sciences, Inc. | 190.60M | 2.58% | 502,170 | - |
| 315 | PRQR | ProQR Therapeutics N.V. | 189.65M | -2.70% | 519,257 | 19.19M |
| 316 | CRBU | Caribou Biosciences, Inc. | 188.44M | 1.04% | 1,019,667 | 11.16M |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 187.53M | 10.89% | 629,534 | - |
| 318 | KPTI | Karyopharm Therapeutics Inc. | 186.66M | 3.50% | 1,019,996 | 146.07M |
| 319 | PLX | Protalix BioTherapeutics, Inc. | 184.51M | -0.43% | 420,247 | 52.74M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 184.39M | 4.01% | 376,940 | 13.11M |
| 321 | DTIL | Precision BioSciences, Inc. | 183.98M | 6.90% | 217,918 | 34.26M |
| 322 | HURA | TuHURA Biosciences, Inc. | 182.47M | 26.43% | 4,111,809 | - |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 181.25M | 1.62% | 464,881 | - |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 180.56M | 3.88% | 127,733 | - |
| 325 | ARTV | Artiva Biotherapeutics, Inc. | 177.47M | 5.43% | 222,622 | 251.00K |
| 326 | SGMT | Sagimet Biosciences Inc. | 176.61M | 2.26% | 330,983 | - |
| 327 | HRTX | Heron Therapeutics, Inc. | 170.95M | 6.30% | 1,598,114 | 154.90M |
| 328 | UNCY | Unicycive Therapeutics, Inc. | 167.07M | -0.15% | 678,586 | - |
| 329 | WHWK | Whitehawk Therapeutics, Inc. | 163.77M | 2.36% | 143,959 | 7.15M |
| 330 | NKTX | Nkarta, Inc. | 163.26M | 5.53% | 594,945 | - |
| 331 | SPRO | Spero Therapeutics, Inc. | 160.94M | 4.12% | 614,591 | 66.80M |
| 332 | CNTB | Connect Biopharma Holdings Limited | 159.96M | 0.35% | 397,022 | 64.00K |
| 333 | AGEN | Agenus Inc. | 159.35M | 4.80% | 1,297,024 | 114.20M |
| 334 | IMUX | Immunic, Inc. | 159.17M | 4.27% | 2,400,078 | - |
| 335 | RNAC | Cartesian Therapeutics, Inc. | 157.20M | -0.84% | 233,251 | 2.80M |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 155.83M | 6.25% | 729,425 | 70.00M |
| 337 | TNYA | Tenaya Therapeutics, Inc. | 155.22M | 3.67% | 2,603,640 | - |
| 338 | GALT | Galectin Therapeutics Inc. | 154.69M | 2.17% | 219,436 | - |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 153.29M | 7.37% | 165,751 | 2.00M |
| 340 | FATE | Fate Therapeutics, Inc. | 152.31M | 5.65% | 2,272,957 | 6.65M |
| 341 | MOLN | Molecular Partners AG | 150.56M | -2.82% | 11,698 | 856.30K |
| 342 | HUMA | Humacyte, Inc. | 148.78M | 3.83% | 4,662,507 | 2.04M |
| 343 | TLSA | Tiziana Life Sciences Ltd | 146.77M | -2.54% | 97,070 | - |
| 344 | KLRS | Kalaris Therapeutics, Inc. | 144.68M | 0.16% | 40,008 | - |
| 345 | REPL | Replimune Group, Inc. | 140.37M | -64.29% | 67,023,965 | - |
| 346 | BMEA | Biomea Fusion, Inc. | 135.92M | 0.53% | 1,349,590 | - |
| 347 | IPHA | Innate Pharma S.A. | 131.30M | 3.55% | 13,470 | 10.57M |
| 348 | ACOG | Alpha Cognition Inc. | 129.99M | -1.00% | 11,617 | 10.22M |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 126.17M | -2.57% | 73,353 | 39.99K |
| 350 | ONCY | Oncolytics Biotech Inc. | 121.93M | 12.90% | 1,368,376 | - |
| 351 | PEPG | PepGen Inc. | 116.80M | 3.05% | 1,110,416 | - |
| 352 | PMN | ProMIS Neurosciences, Inc. | 115.86M | 2.54% | 35,702 | - |
| 353 | GNLX | Genelux Corporation | 112.26M | -0.39% | 173,832 | 8.00K |
| 354 | CBUS | Cibus, Inc. | 110.45M | -3.97% | 844,314 | 3.64M |
| 355 | CRDF | Cardiff Oncology, Inc. | 108.70M | 0.63% | 891,334 | 593.00K |
| 356 | ALDX | Aldeyra Therapeutics, Inc. | 108.33M | 1.12% | 1,488,376 | - |
| 357 | SEER | Seer, Inc. | 108.33M | 13.61% | 3,355,380 | 16.58M |
| 358 | ANTX | AN2 Therapeutics, Inc. | 108.18M | 1.35% | 390,418 | - |
| 359 | EQ | Equillium, Inc. | 107.49M | -5.56% | 326,058 | 4.39M |
| 360 | PYXS | Pyxis Oncology, Inc. | 107.44M | 0.59% | 370,863 | 13.86M |
| 361 | SGMO | Sangamo Therapeutics, Inc. | 106.47M | 2.31% | 5,581,050 | 39.55M |
| 362 | COYA | Coya Therapeutics, Inc. | 104.38M | 6.71% | 208,013 | 7.95M |
| 363 | KZIA | Kazia Therapeutics Limited | 102.73M | 1.93% | 189,771 | 1.27M |
| 364 | TTRX | Turn Therapeutics Inc. | 98.75M | -1.04% | 33,018 | - |
| 365 | EXOZ | eXoZymes, Inc. | 97.51M | -1.71% | 20,664 | -700.00 |
| 366 | VRCA | Verrica Pharmaceuticals Inc. | 96.54M | 9.98% | 87,869 | 35.58M |
| 367 | ANIX | Anixa Biosciences, Inc. | 95.55M | 5.95% | 123,140 | - |
| 368 | GOSS | Gossamer Bio, Inc. | 94.02M | -2.17% | 6,837,552 | 48.47M |
| 369 | LONA | LeonaBio, Inc. | 91.21M | 0.21% | 33,726 | - |
| 370 | INO | Inovio Pharmaceuticals, Inc. | 89.31M | 2.83% | 2,300,273 | 65.34K |
| 371 | VANI | Vivani Medical, Inc. | 88.88M | 0.96% | 169,938 | - |
| 372 | SPRB | Spruce Biosciences, Inc. | 88.51M | 1.38% | 62,441 | 697.00K |
| 373 | AARD | Aardvark Therapeutics, Inc. | 87.48M | 1.78% | 183,007 | - |
| 374 | CGTX | Cognition Therapeutics, Inc. | 87.07M | 7.72% | 1,151,202 | - |
| 375 | PYPD | PolyPid Ltd. | 83.97M | 2.09% | 49,259 | - |
| 376 | MAIA | MAIA Biotechnology, Inc. | 82.51M | 6.25% | 1,131,022 | - |
| 377 | MCRB | Seres Therapeutics, Inc. | 82.25M | 3.12% | 24,907 | 789.00K |
| 378 | PLRX | Pliant Therapeutics, Inc. | 80.49M | 1.56% | 167,615 | - |
| 379 | OKYO | OKYO Pharma Limited | 80.29M | 1.32% | 119,851 | - |
| 380 | CSBR | Champions Oncology, Inc. | 79.71M | -0.17% | 6,964 | 57.95M |
| 381 | ATYR | aTyr Pharma, Inc. | 79.46M | -2.64% | 792,129 | 190.00K |
| 382 | QTTB | Q32 Bio Inc. | 79.15M | 7.13% | 199,311 | 53.74M |
| 383 | GANX | Gain Therapeutics, Inc. | 78.99M | 3.89% | 686,185 | - |
| 384 | FLNA | Filana Therapeutics, Inc. | 78.26M | -1.22% | 275,507 | - |
| 385 | NRXS | NeurAxis, Inc. | 78.20M | 2.19% | 126,280 | 3.57M |
| 386 | FBIO | Fortress Biotech, Inc. | 77.93M | 2.98% | 257,327 | 63.26M |
| 387 | GUTS | Fractyl Health, Inc. | 77.74M | 6.52% | 1,160,640 | 3.00K |
| 388 | RANI | Rani Therapeutics Holdings, Inc. | 77.54M | 5.08% | 1,080,834 | 1.63M |
| 389 | IFRX | InflaRx N.V. | 77.35M | 7.00% | 899,508 | 34.44K |
| 390 | PTHS | Pelthos Therapeutics Inc. | 77.18M | 1.86% | 21,967 | 16.80M |
| 391 | IBIO | iBio, Inc. | 76.00M | 1.85% | 539,593 | 300.00K |
| 392 | IBO | Impact BioMedical Inc. | 75.43M | 1.72% | 161,544 | 32.00K |
| 393 | NRXP | NRx Pharmaceuticals, Inc. | 75.32M | 2.70% | 670,423 | 1.23M |
| 394 | COEP | Coeptis Therapeutics Holdings, Inc. | 75.30M | 1.26% | 22,835 | 1.36M |
| 395 | ESLA | Estrella Immunopharma, Inc. | 74.66M | -4.89% | 95,753 | - |
| 396 | XBIT | XBiotech Inc. | 73.48M | 3.43% | 26,028 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 71.99M | 2.27% | 678,337 | - |
| 398 | BYSI | BeyondSpring Inc. | 71.96M | 0.58% | 2,044 | 1.88M |
| 399 | MNOV | MediciNova, Inc. | 70.88M | -3.36% | 41,221 | 409.66K |
| 400 | ATHE | Alterity Therapeutics Limited | 69.10M | -1.48% | 9,128 | 4.43M |
| 401 | ACET | Adicet Bio, Inc. | 68.26M | -6.07% | 202,431 | - |
| 402 | IMA | ImageneBio, Inc. | 67.67M | 23.42% | 18,660,998 | 800.00K |
| 403 | ICCC | ImmuCell Corporation | 64.32M | 0.42% | 38,015 | 27.64M |
| 404 | CING | Cingulate Inc. | 63.96M | -4.51% | 594,895 | - |
| 405 | DWTX | Dogwood Therapeutics, Inc. | 62.79M | -5.53% | 88,569 | - |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 62.38M | 3.21% | 880,941 | - |
| 407 | TCRX | TScan Therapeutics, Inc. | 61.30M | -2.86% | 7,220,100 | 10.33M |
| 408 | OKUR | OnKure Therapeutics, Inc. | 60.85M | 3.49% | 161,339 | - |
| 409 | PDSB | PDS Biotechnology Corporation | 60.84M | 0.93% | 657,508 | - |
| 410 | GRCE | Grace Therapeutics, Inc. | 59.11M | 6.41% | 573,905 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 57.41M | 4.71% | 28,053 | - |
| 412 | TIL | Instil Bio, Inc. | 56.66M | 3.02% | 27,769 | - |
| 413 | OSTX | OS Therapies Incorporated | 55.49M | 1.54% | 473,289 | - |
| 414 | KZR | Kezar Life Sciences, Inc. | 54.77M | 0.81% | 47,593 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 54.14M | 1.87% | 136,758 | 20.70M |
| 416 | ALGS | Aligos Therapeutics, Inc. | 53.46M | 8.00% | 58,543 | 2.19M |
| 417 | MGX | Metagenomi Therapeutics, Inc. | 52.67M | 1.45% | 130,333 | 25.21M |
| 418 | EDSA | Edesa Biotech, Inc. | 52.43M | 6.88% | 299,118 | - |
| 419 | ENTX | Entera Bio Ltd. | 52.22M | -2.61% | 62,882 | 42.00K |
| 420 | MREO | Mereo BioPharma Group plc | 51.08M | -2.74% | 1,450,894 | 500.00K |
| 421 | RADX | Radiopharm Theranostics Limited | 50.05M | -3.65% | 14,011 | 10.86M |
| 422 | XLO | Xilio Therapeutics, Inc. | 48.92M | -0.59% | 20,588 | 43.77M |
| 423 | NTRB | Nutriband Inc. | 48.38M | 2.05% | 5,098 | 2.28M |
| 424 | ANVS | Annovis Bio, Inc. | 47.07M | 4.40% | 2,496,057 | - |
| 425 | CUE | Cue Biopharma, Inc. | 46.13M | -5.90% | 13,410,297 | 27.47M |
| 426 | RNXT | RenovoRx, Inc. | 45.95M | 3.52% | 197,358 | 1.12M |
| 427 | ATOS | Atossa Therapeutics, Inc. | 45.73M | 7.49% | 71,410 | - |
| 428 | LSTA | Lisata Therapeutics, Inc. | 45.07M | -0.40% | 223,468 | 170.00K |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | 6.56% | 75,550 | - |
| 430 | HOWL | Werewolf Therapeutics, Inc. | 44.59M | 8.08% | 147,881 | 1.14M |
| 431 | RLYB | Rallybio Corporation | 43.90M | -1.66% | 57,136 | 858.00K |
| 432 | NXTC | NextCure, Inc. | 43.86M | 5.84% | 84,621 | - |
| 433 | RNTX | Rein Therapeutics Inc. | 43.46M | 4.03% | 81,377 | - |
| 434 | ACTU | Actuate Therapeutics, Inc. | 43.16M | 5.81% | 125,002 | - |
| 435 | LITS | Lite Strategy, Inc. | 41.45M | -1.72% | 173,604 | - |
| 436 | HYPD | Hyperion DeFi, Inc. | 40.44M | -2.20% | 500,729 | 813.46K |
| 437 | SNSE | Sensei Biotherapeutics, Inc. | 40.41M | 0.87% | 42,663 | - |
| 438 | ATRA | Atara Biotherapeutics, Inc. | 39.99M | 5.16% | 91,774 | 120.77M |
| 439 | VERU | Veru Inc. | 38.20M | - | 39,166 | 16.89M |
| 440 | IMMP | Immutep Limited | 37.46M | -1.56% | 867,139 | 5.28M |
| 441 | CRVO | CervoMed Inc. | 37.13M | 4.70% | 23,661 | 4.01M |
| 442 | PSTV | Plus Therapeutics, Inc. | 37.12M | 12.71% | 674,604 | 5.21M |
| 443 | CELU | Celularity Inc. | 36.91M | 0.79% | 8,207 | 40.58M |
| 444 | PASG | Passage Bio, Inc. | 34.68M | 9.30% | 42,773 | - |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 34.61M | 2.78% | 97,867 | 90.00K |
| 446 | EVAX | Evaxion A/S | 34.53M | 2.48% | 11,790 | 7.53M |
| 447 | ABVC | ABVC BioPharma, Inc. | 34.10M | -3.50% | 91,902 | 797.92K |
| 448 | LIXT | Lixte Biotechnology Holdings, Inc. | 34.04M | -3.93% | 31,097 | - |
| 449 | PTN | Palatin Technologies, Inc. | 34.01M | 2.72% | 20,216 | 8.96M |
| 450 | PLUR | Pluri Inc. | 33.58M | 0.62% | 1,267 | 1.34M |
| 451 | INMB | INmune Bio Inc. | 32.97M | 5.08% | 263,994 | 50.00K |
| 452 | LGVN | Longeveron Inc. | 32.79M | -3.45% | 818,084 | 1.20M |
| 453 | CVM | CEL-SCI Corporation | 32.53M | -1.23% | 16,557 | - |
| 454 | APLM | Apollomics, Inc. | 31.63M | 8.31% | 7,701 | 6.93M |
| 455 | DYAI | Dyadic International, Inc. | 31.16M | -4.01% | 22,543 | 3.09M |
| 456 | BCTX | BriaCell Therapeutics Corp. | 30.73M | 2.34% | 82,183 | - |
| 457 | TPST | Tempest Therapeutics, Inc. | 30.70M | 4.39% | 565,894 | - |
| 458 | MRKR | Marker Therapeutics, Inc. | 29.01M | -0.57% | 50,477 | 3.55M |
| 459 | KYNB | Kyntra Bio, Inc. | 28.65M | -1.26% | 28,373 | 6.44M |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 28.52M | 4.83% | 25,570 | - |
| 461 | IGC | IGC Pharma, Inc. | 28.46M | -1.62% | 532,390 | 1.11M |
| 462 | SNTI | Senti Biosciences, Inc. | 28.07M | 3.26% | 70,841 | 22.00K |
| 463 | BOLD | Boundless Bio, Inc. | 26.89M | 6.19% | 193,697 | - |
| 464 | OTLK | Outlook Therapeutics, Inc. | 26.61M | 2.17% | 2,085,232 | 205.70K |
| 465 | DARE | Daré Bioscience, Inc. | 25.92M | -2.73% | 9,980 | 1.03M |
| 466 | JSPR | Jasper Therapeutics, Inc. | 25.73M | 14.55% | 627,026 | - |
| 467 | NRSN | NeuroSense Therapeutics Ltd. | 25.13M | 1.54% | 77,379 | - |
| 468 | LTRN | Lantern Pharma Inc. | 24.88M | 12.69% | 283,260 | - |
| 469 | CRIS | Curis, Inc. | 24.78M | 24.00% | 1,071,931 | 9.44M |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 24.64M | -4.39% | 42,915 | 14.99M |
| 471 | XCUR | Exicure, Inc. | 24.53M | 1.88% | 21,528 | 500.00K |
| 472 | LEXX | Lexaria Bioscience Corp. | 24.39M | 7.69% | 155,270 | 368.00K |
| 473 | SER | Serina Therapeutics, Inc. | 24.14M | -1.01% | 208,751 | 130.00K |
| 474 | SKYE | Skye Bioscience, Inc. | 24.13M | 0.40% | 85,882 | - |
| 475 | TVGN | Tevogen Bio Holdings Inc. | 23.24M | -2.62% | 23,976 | - |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 22.82M | 2.78% | 1,257,173 | 789.00K |
| 477 | BRNS | Barinthus Biotherapeutics plc | 22.47M | -3.08% | 27,710 | 14.97M |
| 478 | NNVC | NanoViricides, Inc. | 22.46M | 5.83% | 107,840 | - |
| 479 | AEON | AEON Biopharma, Inc. | 21.75M | 2.31% | 46,531 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.82M | 2.43% | 41,976 | 570.00K |
| 481 | COCP | Cocrystal Pharma, Inc. | 19.71M | 14.40% | 350,849 | - |
| 482 | QNTM | Quantum BioPharma Ltd. | 19.62M | -4.82% | 143,796 | - |
| 483 | PLRZ | Polyrizon Ltd. | 19.29M | 9.79% | 109,410 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 18.83M | 7.86% | 242,023 | - |
| 485 | ALLR | Allarity Therapeutics, Inc. | 18.82M | -6.30% | 220,848 | 320.00K |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 18.24M | 1.24% | 189,108 | 3.94M |
| 487 | OSRH | OSR Holdings, Inc. | 17.86M | 0.80% | 688,891 | 2.91M |
| 488 | LPCN | Lipocine Inc. | 17.37M | 8.18% | 838,021 | 1.98M |
| 489 | ICU | SeaStar Medical Holding Corporation | 16.81M | 13.48% | 78,079 | 1.23M |
| 490 | HIND | Vyome Holdings, Inc. | 16.28M | 5.94% | 22,851 | 319.71K |
| 491 | GNTA | Genenta Science S.p.A. | 15.16M | -3.95% | 72,912 | - |
| 492 | MBRX | Moleculin Biotech, Inc. | 14.51M | 3.82% | 68,428 | - |
| 493 | JUNS | Jupiter Neurosciences, Inc. | 14.48M | 0.05% | 84,035 | 21.80K |
| 494 | PHIO | Phio Pharmaceuticals Corp. | 14.41M | 2.48% | 161,876 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 13.87M | -0.73% | 21,209 | - |
| 496 | INAB | IN8bio, Inc. | 13.29M | -2.88% | 55,266 | - |
| 497 | BCDA | BioCardia, Inc. | 13.02M | 0.85% | 137,840 | 3.00K |
| 498 | TRAW | Traws Pharma, Inc. | 12.87M | 8.78% | 21,635 | 2.85M |
| 499 | KAPA | Kairos Pharma, Ltd. | 12.53M | 0.31% | 94,880 | - |
| 500 | CVKD | Cadrenal Therapeutics, Inc. | 12.51M | 4.83% | 15,528 | - |